iPatientCare Introduces Patient Centric Apps for iPhone and iPad, Addition to its mHealth Solutions

Los Angeles, CA,  July 16, 2014 -- iPatientCare, Inc., a pioneer in mHealth and cloud based ambulatory EHR, Integrated Practice Management and Patient Portal Solutions, today introduced miMeds, miCalc and miWater, innovative patient Centric Medical Apps for free on iPhone and iPad on the App Store. It will help patients and clinicians to remain updated about patient's health, and improve the level of care.

The healthcare industry is moving towards a delivery model that is more patient-focused, value-based, and accessible even in remote environments. In this regard, iPatientCare is all set to add value to the digital evolution in healthcare by creating cutting-edge, and innovative mHealth solutions.

While announcing the product release, Kedar Mehta, CTO, iPatientCare commented, “We are proud to launch innovative cutting edge patient-centered Medical Apps for healthcare. Our expertise in data, analytics, technology, and health care strategy are critical additions to our product suite, which aims to improve healthcare cost, quality, and patient satisfaction."

Kedar Mehta highlighted the usability of three iPhone and iPad based Medical Apps –

  • miMeds (pronounced as “my Meds”), brought to you by iPatientCare, is an incredible reminder app for medications and nutritional supplements. The application, created considering Medication Adherence, acts as a comprehensive personal medication reminder App for your iPhone and iPad.
  • miCalc (pronounced as “my Calc” representing mobile iPatientCare Calculator) is an application dedicated to pregnant mothers, who can take better care of themselves by analyzing vital measurements such as body mass index, body surface area, Ideal body weight, Due date by LMP, Due date by Ultrasound, and gestational age. Benefit of this application isn’t restricted to pregnant mothers but also empowers the society to fight many other diseases such as obesity.
  • miWater (pronounced as “my water”) lets you keep a track of how much water you have consumed in a given day. Use miWater to set a daily intake goal of how much water you would like to consume daily. miWater will notify you if your falling behind on your daily water intake goal.

Udayan Mandavia, President/CEO, iPatientCare excitedly commented “We have been a pioneer in providing mHealth solution to physician community. Over the years, we have constantly been actively making contributions to empower physician and patient communities. In early 90’s, we had empowered medical students for patient records solutions on their palm pilot and continued with many other initiatives such as CMS Designated Test EHR. The launch of the three iPhone and iPad based medical applications is another contribution by iPatientCare to empower patients and provide them the basic health education.”

These Apps are available to the healthcare community and users simply need to download the App from iTunes, and the application is ready to use.

About iPatientCare:

iPatientCare, Inc. is a privately held medical informatics company based at Woodbridge, New Jersey. The company’s unified product suite that include Electronic Health/Medical Record and integrated Practice Management/Billing System, Patient Portal/PHR, Health Information Exchange (HIE), and mobile point-of-care solutions for both ambulatory and acute/sub-acute market segments. iPatientCare has been recognized as a preferred/MU partner by numerous Regional Extension Centers (REC), hospitals/health systems, and academies, and additionally, has been designated as a Test EHR by the CMS.

iPatientCare EHR 2014 (2.0) has received 2014 Edition Ambulatory Complete EHR certification by ICSA Labs, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB), in accordance with the applicable eligible professional certification criteria adopted by the Secretary of Health and Human Services (HHS).

Full certification details can be found at ONC Certified Health IT Product List.

The ONC 2014 Edition criteria support both Stage 1 and 2 Meaningful Use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

Visit http://www.iPatientCare.com for more information.

Contact:

iPatientCare, Inc.

One Woodbridge Center, Suite 812, Woodbridge, New Jersey 07095
Phone: 800-741-0981 | Fax: 732.676.7667 | Email: info(at)ipatientcare(dot)com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.